本报告从机构数量规模、类别、地域分布、上市情况和经营状况等维度,分析2022年社会办医·医院集团100强和上市医疗服务企业50强排行榜,了解社会办医·医院集团及上市医疗服务企业竞争力发展变化情况。对比研究发现,2022年社会办医·医院集团规模不断扩大,专科领域中眼科和妇儿占据优势。华东和华北地区仍是社会办医·医院集团总部的主要集中地,北京和上海继续位居前列,总部所在地新增1家海外城市。2022年上市医疗服务企业50强竞争激烈,榜单名次较上年度变化较大,企业竞争力不断提升,出现“有机增长”,社会办医即将进入从量变到质变转型的关键期。2022年国家加强了上市医疗服务企业和首发企业的现场检查,资本市场管理更加严格和规范。集团化发展和上市是专科医院集团未来两大发展方向。
<<The report analyzes the top 100 social medical groups and top 50 listed medical service enterprises in 2021 from the dimensions of number,size,category,geographical distribution,listing and operating status,and understands the development and changes of competitiveness of social medical groups and listed medical service enterprises. hrough the comparative study,it is found that in 2021,the scale of social hospital groups will continue to expand,and ophthalmology and women and children occupy the main advantages in specialty areas. East and North China remain the main centers of social medical group headquarters,with Beijing and Shanghai continuing to top the list,with one new overseas city added. In 2021,the top 50 listed medical service enterprises face fierce competition,the ranking of the list changes greatly,the competitiveness of enterprises is constantly improving,and there is “organic growth”. The social medical industry is about to enter a critical period of transformation from quantitative change to qualitative change. In 2021,the government will strengthen the on-site inspection of listed medical service enterprises and IPO enterprises,and the capital market management will be more strict and standardized. In the future,collectivization development and listing are two major development directions of specialized hospital group.
<<Keywords: | CompetitivenessMedical ServiceListed EnterprisePrivate Hospital GroupPrivate Medical Service |